News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CardioDx, Inc. Aims for $92 Million IPO


11/6/2013 7:43:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

California's CardioDx details the structure of its $92 million initial public offering, going for $14-$16 per share. CardioDx aims for $92M IPO. California molecular diagnostics company CardioDx unveiled new details of its initial public offering, slated to raise $92 million through shares priced at $14-$16 apiece. Once the IPO launches, CardioDx will trade on the Nasdaq stock market under the symbol "CDX."

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES